CompletedPhase 2NCT00039351

Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma

Studying Angioimmunoblastic T-cell lymphoma

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Principal Investigator: Pierre Soubeyran, MD, PhD
Institut Bergonié
Intervention: cyclophosphamide(drug)
Enrollment: 32 enrolled
Eligibility: 70 years · All sexes
Timeline: 2002

Study locations (17)

Ziekenhuis Network Antwerpen Middelheim, Antwerp, Belgium
Centre Hospitalier Universitaire Brugmann, Brussels, Belgium
U.Z. Gasthuisberg, Leuven, Belgium
National Cancer Institute of Egypt, Cairo, Egypt
Centre D'Oncologie Du Pays-Basque, Bayonne, France
Hopital Saint Andre, Bordeaux, France
Institut Bergonie, Bordeaux, France
Centre Hospitalier de Dax, Dax, France
Hopital Robert Boulin, Libourne, France
Polyclinique de Francheville, Périgueux, France
Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
Academisch Ziekenhuis Groningen, Groningen, Netherlands
University Medical Center Nijmegen, Nijmegen, Netherlands
Hospitais da Universidade de Coimbra (HUC), Coimbra, Portugal
Hopitaux Universitaires de Geneve, Thonex-Geneve, Switzerland
+2 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00039351 on ClinicalTrials.gov

Other trials for Angioimmunoblastic T-cell lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Angioimmunoblastic T-cell lymphoma →

← Back to all trials